Literature DB >> 19243571

AMP-activated protein kinase and cancer.

W Wang1, K-L Guan.   

Abstract

AMP-activated protein kinase (AMPK) is a cellular energy sensor that is conserved in eukaryotes. Elevated AMP/ATP ratio activates AMPK, which inhibits energy-consuming processes and activates energy-producing processes to restore the energy homeostasis inside the cell. AMPK activators, metformin and thiazolidinediones, are used for the treatment of type II diabetes. Recently, reports have indicated that AMPK may also be a beneficial target for cancer treatment. Cancer cells have characteristic metabolic changes different from normal cells and, being a key metabolic regulator, AMPK may regulate the switch. AMPK may act to inhibit tumorigenesis through regulation of cell growth, cell proliferation, autophagy, stress responses and cell polarity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243571     DOI: 10.1111/j.1748-1716.2009.01980.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  69 in total

Review 1.  The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer.

Authors:  Geoffrey D Girnun
Journal:  Semin Cell Dev Biol       Date:  2012-01-21       Impact factor: 7.727

2.  Diabetes, insulin and cancer risk.

Authors:  Xi-Lin Yang; Juliana Cn Chan
Journal:  World J Diabetes       Date:  2012-04-15

3.  Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH.

Authors:  Erin E Mendoza; Michael G Pocceschi; Xiangul Kong; Dennis B Leeper; Jaime Caro; Kirsten H Limesand; Randy Burd
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

Review 4.  Cardiovascular disease and cancer: Evidence for shared disease pathways and pharmacologic prevention.

Authors:  Farzad Masoudkabir; Nizal Sarrafzadegan; Carolyn Gotay; Andrew Ignaszewski; Andrew D Krahn; Margot K Davis; Christopher Franco; Arya Mani
Journal:  Atherosclerosis       Date:  2017-06-02       Impact factor: 5.162

5.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.

Authors:  Kristin M Nieman; Hilary A Kenny; Carla V Penicka; Andras Ladanyi; Rebecca Buell-Gutbrod; Marion R Zillhardt; Iris L Romero; Mark S Carey; Gordon B Mills; Gökhan S Hotamisligil; S Diane Yamada; Marcus E Peter; Katja Gwin; Ernst Lengyel
Journal:  Nat Med       Date:  2011-10-30       Impact factor: 53.440

6.  Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.

Authors:  Maral Jamshidi; Marjanka K Schmidt; Thilo Dörk; Montserrat Garcia-Closas; Tuomas Heikkinen; Sten Cornelissen; Alexandra J van den Broek; Peter Schürmann; Andreas Meyer; Tjoung-Won Park-Simon; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Garrett Teoh Hor Keong; Astrid Irwanto; Marko Laakso; Sampsa Hautaniemi; Kristiina Aittomäki; Carl Blomqvist; Jianjun Liu; Heli Nevanlinna
Journal:  Int J Cancer       Date:  2012-10-25       Impact factor: 7.396

Review 7.  Effects of AMP-activated protein kinase in cerebral ischemia.

Authors:  Jun Li; Louise D McCullough
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-16       Impact factor: 6.200

8.  Autophagy: resetting glutamine-dependent metabolism and oxygen consumption.

Authors:  Tsung-Chin Lin; Yun-Ru Chen; Elizabeth Kensicki; Angela Ying-Jian Li; Mei Kong; Yang Li; Robert P Mohney; Han-Ming Shen; Bangyan Stiles; Noboru Mizushima; Liang-In Lin; David K Ann
Journal:  Autophagy       Date:  2012-08-21       Impact factor: 16.016

9.  Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research.

Authors:  Bruce B Duncan; Maria I Schmidt
Journal:  Diabetes Care       Date:  2009-09       Impact factor: 19.112

10.  Targeting insulin and insulin-like growth factor pathways in epithelial ovarian cancer.

Authors:  Marie-Claude Beauchamp; Amber Yasmeen; Ariane Knafo; Walter H Gotlieb
Journal:  J Oncol       Date:  2010-01-05       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.